Free Trial

Raymond James Financial Inc. Takes Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background
Remove Ads

Raymond James Financial Inc. acquired a new position in shares of Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 129,261 shares of the business services provider's stock, valued at approximately $5,552,000. Raymond James Financial Inc. owned approximately 0.07% of Genpact at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Stifel Financial Corp purchased a new position in Genpact during the 3rd quarter worth approximately $1,197,000. Blue Trust Inc. grew its position in shares of Genpact by 8.7% during the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after acquiring an additional 441 shares during the last quarter. Burney Co. increased its holdings in shares of Genpact by 242.8% in the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock valued at $5,618,000 after acquiring an additional 92,641 shares during the period. KBC Group NV purchased a new stake in Genpact in the 4th quarter valued at $298,000. Finally, JPMorgan Chase & Co. boosted its stake in Genpact by 192.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after purchasing an additional 2,060,595 shares during the period. Hedge funds and other institutional investors own 96.03% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have commented on G shares. Mizuho lifted their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Needham & Company LLC upped their price objective on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and lifted their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $48.44.

Remove Ads

Get Our Latest Analysis on Genpact

Insider Activity at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by company insiders.

Genpact Price Performance

NYSE:G traded up $0.62 during trading hours on Tuesday, hitting $50.55. The company's stock had a trading volume of 1,420,107 shares, compared to its average volume of 1,295,944. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The business's 50-day moving average is $50.38 and its two-hundred day moving average is $44.78. The company has a market capitalization of $8.88 billion, a PE ratio of 17.80, a PEG ratio of 1.84 and a beta of 1.16.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, research analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact's dividend payout ratio (DPR) is presently 23.94%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads